Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

FDA clears its IND for new immunotherapeutic for treating prostate cancer

FDA clears its IND for new immunotherapeutic for treating prostate cancer

Cancer survivors could be at greater risk of cardiovascular diseases

Cancer survivors could be at greater risk of cardiovascular diseases

Study finds increase in Medicaid-covered preemptive kidney transplants after Medicaid expansion

Study finds increase in Medicaid-covered preemptive kidney transplants after Medicaid expansion

Chemists develop new approach based on graphene nanoflakes for drug delivery

Chemists develop new approach based on graphene nanoflakes for drug delivery

Trump administration hits brakes on law to curb unneeded Medicare CT scans, MRIs

Trump administration hits brakes on law to curb unneeded Medicare CT scans, MRIs

Roswell Park receives more than $15 million in grants for cancer research

Roswell Park receives more than $15 million in grants for cancer research

New oral androgen deprivation therapy increases risk of death in cardiovascular patients

New oral androgen deprivation therapy increases risk of death in cardiovascular patients

Advanced imaging technology for prostate cancer could increase a man’s chances of survival

Advanced imaging technology for prostate cancer could increase a man’s chances of survival

Study finds attractive therapeutic target for treatment of Kennedy's disease and prostrate cancer

Study finds attractive therapeutic target for treatment of Kennedy's disease and prostrate cancer

UCLA researchers discover link between progenitor cells and age-related prostate growth

UCLA researchers discover link between progenitor cells and age-related prostate growth

New 'bone in a dish' could help explore fundamental disease processes

New 'bone in a dish' could help explore fundamental disease processes

New blood test can detect clinically significant prostate cancer in high-risk patients

New blood test can detect clinically significant prostate cancer in high-risk patients

HIV-infected elderly cancer patients have worse outcomes despite treatment

HIV-infected elderly cancer patients have worse outcomes despite treatment

Adjuvant radiotherapy may help treat locally advanced prostate cancer

Adjuvant radiotherapy may help treat locally advanced prostate cancer

Researchers identify key to controlling growth and progression of prostate cancer

Researchers identify key to controlling growth and progression of prostate cancer

Common feature that makes cancer cells appear bloated could be their potential weak spot

Common feature that makes cancer cells appear bloated could be their potential weak spot

Study reveals how aggressive prostate cancer metastasizes by evading the immune system

Study reveals how aggressive prostate cancer metastasizes by evading the immune system

Mathematical model helps quantify metastatic cell behavior

Mathematical model helps quantify metastatic cell behavior

AI-enabled device detects if targeted chemotherapy is working

AI-enabled device detects if targeted chemotherapy is working

New research uncovers mechanism behind the newest generation of cancer drugs

New research uncovers mechanism behind the newest generation of cancer drugs